N
PRTA icon

Nuveen’s Prothena Corp PRTA Stock Holding History

Nuveen’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,800
Closed -$669K – 3231
2023
Q2 		$669K Buy
+9,800
New +$632K ﹤0.01% 2835

Other funds holding PRTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen's PRTA Position: Q1 2026 in Review

Nuveen increased its Prothena Corp (PRTA) stake by 0.03% in Q1 2026, buying an estimated $2.39K and bringing the position to 759,368 shares worth $7.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Nuveen first reported a position in PRTA in Q1 2016 and has held it in 35 quarters since. The position peaked at $34.5M in Q4 2022. 185 funds tracked by Wall St. Rank hold PRTA as of Q1 2026.

  • Nuveen held 759,368 shares of Prothena Corp worth $7.38M as of Q1 2026.
  • Nuveen bought 261 Prothena Corp shares in Q1 2026, an estimated $2.39K.
  • Prothena Corp made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #1720 holding.
  • Nuveen first reported a position in Prothena Corp in Q1 2016 and has held it in 35 quarters since.
  • Nuveen's Prothena Corp position peaked at $34.5M in Q4 2022.
  • 185 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.